People with TB in Mizoram are dying in rising numbers, and those most at risk can't easily get help to see long treatment through.
People being treated for tuberculosis in Mizoram
Where it stands
- Sourced (done)
- Kit (done)
- Wanted (next)
- Building
- Solved
How this problem came to be
- Found1 sourcethehindu.com
- Quoted5 claimseach checked against its page
- BriefWrittenand what solved looks like
- Market3 signals145 people
- Kit5 steps21 tools · 6 routes
- People0 want0 live it · 0 would test
The problem, broken down
- Who it hurts
- TB patients in Mizoram, especially in Aizawl district, and those with multi-drug-resistant TB or TB with HIV.
- The moment
- Weeks into treatment, when side effects, travel and lost work make it hard to keep taking medicines and attending check-ups.
- What people do today
- Patients are tracked through the national TB programme, and community support comes from people who sign up to adopt patients on the Ni-kshay platform.
- Why it's unsolved
- Deaths have risen every year since 2020 even as new cases held roughly steady, and the published figures don't show which patients are dying or why, so support can't be aimed at them.
- What solved looks like
- A Mizo-language companion for TB patients and their families that sends dose and appointment reminders, flags missed doses or worrying symptoms to the treatment supporter, and connects high-risk patients to nutrition support and community donors.
Evidence
Every claim is tied to the source it comes from- 1A total of 145 people died of tuberculosis in Mizoram in 2025, the highest fatalities in six years.
- 2TB deaths rose from 31 in 2020 to 46 in 2021, 87 in 2022, 119 in 2023 and 136 in 2024.
- 32,275 people, including 911 females, were diagnosed with TB in 2025, a marginal decrease from 2024's record of 2,291 cases.
- 4Of the new cases, 146 people had multi-drug-resistant TB and 267 had both TB and HIV/AIDS.
- 5Aizawl district recorded the highest number of cases at 1,569.
Builders still need to know
- Which patients are dying: late diagnosis, drug resistance, HIV co-infection or dropping out of treatment?
- Would the National TB Elimination Programme in Mizoram let a companion tool read treatment schedules from Ni-kshay?
- Would churches and youth groups, central to community life in Mizoram, act as treatment supporters?
Written from the cited sources. Anything they don't say is left as a question, not a guess.
Sources
From a public page with a citation.
What the source says, in short
A total of 145 people died of tuberculosis in Mizoram in 2025, the highest fatalities in six years. TB deaths rose from 31 in 2020 to 46 in 2021, 87 in 2022, 119 in 2023 and 136 in 2024. 2,275 people, including 911 females, were diagnosed with TB in 2025, a marginal decrease from 2024's record of 2,291 cases. Of the new cases, 146 people had multi-drug-resistant TB and 267 had both TB and HIV/AIDS. Aizawl district recorded the highest number of cases at 1,569.
Forks 0
Nobody has forked this yet. Be the first.
Market read
How big this is, from the evidence
- The Hindu: At 145, Mizoram recorded six-year high TB deaths in 2025 (Jan 2026) ↗Who it touches · High confidence145 people“A total of 145 people died of tuberculosis in Mizoram in 2025, the highest fatalities in six years.”
- The Hindu: At 145, Mizoram recorded six-year high TB deaths in 2025 (Jan 2026) ↗Who it touches · High confidence2,275 people“2,275 people, including 911 females, were diagnosed with TB in 2025, a marginal decrease from 2024's record of 2,291 cases.”
- The Hindu: At 145, Mizoram recorded six-year high TB deaths in 2025 (Jan 2026) ↗Who it touches · High confidence146 people“Of the new cases, 146 people had multi-drug-resistant TB and 267 had both TB and HIV/AIDS.”
How these were measured: A figure quoted in the problem's evidence, checked against its source when the brief was written.
For whoever takes this up
The builder's path for this problem
Five steps, each with the tools that fit this problem and a word to carry with you. A starter prompt is ready to paste into any assistant.
Open the pathDiscussion 0
No comments yet.